ELOX — Eloxx Pharmaceuticals Cashflow Statement
0.000.00%
Last trade - 00:00- $2.17m
- $2.83m
Annual cashflow statement for Eloxx Pharmaceuticals, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2018 December 31st | 2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -47.2 | -50.9 | -34.6 | -66.7 | -36.1 |
| Depreciation | |||||
| Non-Cash Items | 13.4 | 12 | 9.75 | 32.6 | 4.26 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 2.22 | -0.644 | -3.4 | -1.03 | -0.118 |
| Change in Prepaid Expenses | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Change in Taxes Payable | |||||
| Net Change in Other Assets & Liabilities | |||||
| Cash from Operating Activities | -31.4 | -39.4 | -28.2 | -35 | -31.8 |
| Capital Expenditures | -0.235 | -0.04 | — | -0.089 | -0.066 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | -0.082 | -33.5 | 33.8 | 2.15 | 0 |
| Sale of Business | |||||
| Sale of Fixed Assets | |||||
| Change in Net Investments | |||||
| Purchase of Investments | |||||
| Cash from Investing Activities | -0.317 | -33.5 | 33.8 | 2.06 | -0.066 |
| Financing Cash Flow Items | 2.17 | -1.25 | 0.277 | 2.56 | 8.81 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 56.2 | 46.8 | -3.44 | 50.8 | 8.81 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 24.5 | -26.1 | 2.19 | 17.8 | -23.1 |